EBF1 and coronary artery disorder: Genome-wide association studies (GWAS) have linked EBF1 to multiple human cardiovascular disorders, including coronary heart disease 19-22, cardiovascular metabolic disease 23 and orthostatic hypotension 24, implying its potential roles in the human cardiac system.